Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Metal-on-metal hip resurfacing arthroplasty (MoMHRA) was introduced in 1997 and has become an established surgical option, especially for younger patients with end-stage osteoarticular disease (Daniel et al. 2011). Designer and non-designer data continue to support the use of MoMHRA for this cohort of patients despite pseudotumour becoming an acknowledged complication (Murray et al. 2012; Treacy et al. 2011). The rates of pseudotumour are variable, and concern amongst the general public, healthcare providers and government is increasing together with the potential revision burden on hip services particularly compounded by poor reported outcomes post-revision (Glyn-Jones et al. 2009; Pandit et al. 2008; Hart et al. 2009; Kwon et al. 2011; Grammatopolous et al. 2009; Carrothers et al. 2010).

Original publication





Book title

Total Hip Arthroplasty: Tribological Considerations and Clinical Consequences

Publication Date



75 - 83